Washington Trust CO Cti Biopharma Corp Transaction History

Washington Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$0.64 - $0.92 $10,240 - $14,720	-16,000 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$0.9 - $1.37 $2,700 - $4,110	-3,000 Reduced 15.79%	16,000 $15,000
Q4 2017 Feb 05, 2018	SELL	$2.47 - $3.34 $30,628 - $41,416	-12,400 Reduced 39.49%	19,000 $51,000
Q3 2017 Oct 31, 2017	BUY	$3.12 - $3.65 $97,968 - $114,610	31,400	31,400 $100,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.